** Shares of medical device maker Becton Dickinson BDX.N rise 1.6% to $147.1 premarket

** Co raises full-year profit forecast on strong demand for its medical and surgical products

** Expects 2026 adjusted EPS between $12.52 and $12.72 vs previous forecast of $12.35 to $12.65

** Appoints Vitor Roque as chief financial officer, effective May 7

** We would have liked to see more organic earnings upside in the quarter... but a better top-line performance and Vitor Roque's formal appointment as CFO still look like small steps in the right direction - J.P. Morgan analysts

** BD reports Q1 adjusted EPS of $2.90 vs analysts' average estimate of $2.77 - LSEG-compiled data

** Q1 revenue of $4.71 billion tops estimates of $4.67 billion

** Up to last close, stock down 5% YTD